Received: 30 June 2020
Revised: 14 September 2020
Accepted: 26 October 2020
First Online: 8 November 2020
Compliance with ethical standards
: CNBM reports personal fees from iRhythm, other from Sanofi, other from Abbott Diagnostics, during the conduct of the study. CJP reports grants from NIH/NHLBI, during the conduct of the study; grants from NIH/NCATS, grants from BioCardia BC-14-001-02; Mesoblast, Inc. MSB-MPC-CHF001; Ventrix, Inc.; Athersys Inc. AMI MultiStem; Verily Life Sciences LLC-Project Baseline OSMB; Ironwood MSB-MPC-CHF00-DMC, Imbria Pharmaceuticals Inc.; Milestone Pharmaceuticals Inc.; Caladrius Biosciences, Inc.; Gatorade Trust; and McJunkin Family Foundation, outside the submitted work. The other authors declare they have no actual or potential competing financial interests.